Back to search results

Nabilone for Agitation in Frontotemporal Dementia

Abroad (travel likely)RecruitingPHASE2

Conditions

Frontotemporal Dementia · Frontotemporal Dementia, Behavioral Variant · Primary Progressive Aphasia · bvFTD · PPA · FTD

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Benita Mudge) · Benita.Mudge@vch.ca · 604 822 7990
    Contact: Principal Investigator (Robin Hsiung, MD)

  • Brain and Mind Institute, University of Western Ontario, London, Ontario, Canada

    Contact: Study coordinator (Kristy Coleman) · kristy.coleman@sjhc.london.on.ca
    Contact: Principal Investigator (Elizabeth Finger, MD)

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Ljubica Zotovic, MD) · Ljubica.Zotovic@sunnybrook.ca
    Contact: Principal Investigator (Mario Masellis, MD)

  • Baycrest Hospital, University of Toronto, Toronto, Ontario, Canada

  • Western Hospital - University of Toronto, Toronto, Ontario, Canada

    Contact: Study coordinator (Kasey Cortez) · Kasey.Cortez@uhn.ca
    Contact: Principal Investigator (Carmela Tartaglia, MD)

  • CHU de Québec, Université Laval, Laval, Quebec, Canada

    Contact: Study coordinator (Mary-Christine Bourgeois) · mary-christine.bourgeois@chudequebec.ca
    Contact: Study coordinator (Cassandra Roy) · cassandra.roy@crchudequebec.ulaval.ca · 418-525-4444
    Contact: Principal Investigator (Robert LaForce Jr, MD)

  • The Douglas Research Centre, Montreal, Quebec, Canada

    Contact: Study coordinator (Ahmad Fakhoury, MA) · ahmad.fakhoury.comtl@ssss.gouv.qc.ca · +1 (514) 761 6131
    Contact: Principal Investigator (Simon Ducharme, MA, MD)
View source on ClinicalTrials.gov(opens in a new tab)